\relax 
\@writefile{toc}{\boolfalse {citerequest}\boolfalse {citetracker}\boolfalse {pagetracker}\boolfalse {backtracker}\relax }
\@writefile{lof}{\boolfalse {citerequest}\boolfalse {citetracker}\boolfalse {pagetracker}\boolfalse {backtracker}\relax }
\@writefile{lot}{\boolfalse {citerequest}\boolfalse {citetracker}\boolfalse {pagetracker}\boolfalse {backtracker}\relax }
\abx@aux@refcontext{none/global//global/global}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {section}{\numberline {1}Overview of proposed approach and notation}{2}{}\protected@file@percent }
\newlabel{sec:intro}{{1}{2}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{\numberline {1.1}Data structure of PTM quantification experiments.}{2}{}\protected@file@percent }
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S1}{\ignorespaces Representation of the data of modified peptides at one site and unmodified peptides of the same protein, with $I$ conditions and $J$ replicate runs. Abundances of the PTM and protein are quantified by multiple spectral features (peptide ions, $K$ for modified peptides and $L$ for unmodified peptides). Some spectral features can be missing (shown as $-$), either randomly in individual runs or completely in certain conditions. In real practice, the number of runs can vary across conditions. \relax }}{2}{}\protected@file@percent }
\providecommand*\caption@xref[2]{\@setref\relax\@undefined{#1}}
\newlabel{fig:dtable}{{S1}{2}}
\abx@aux@cite{Ritchie_15a}
\abx@aux@segm{0}{0}{Ritchie_15a}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {section}{\numberline {2}Existing methods}{3}{}\protected@file@percent }
\newlabel{sec:ttest}{{2}{3}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{\numberline {2.1}Two-sample $t$-test}{3}{}\protected@file@percent }
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{\numberline {2.2}Limma}{3}{}\protected@file@percent }
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {section}{\numberline {3}Proposed approach}{4}{}\protected@file@percent }
\newlabel{sec:prop}{{3}{4}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{\numberline {3.1}Design of PTM experiments}{4}{}\protected@file@percent }
\newlabel{sec:complex_design}{{3.1}{4}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S2}{\ignorespaces Different models that are fit depending on the experimental design. Models are fit for Label-free and TMT acquisition methods, as well as group comparison and time course experimental designs. The estimation of standard error and degrees of freedom for each model is shown. \relax }}{5}{}\protected@file@percent }
\newlabel{fig:statistical_inference}{{S2}{5}}
\abx@aux@cite{Chiva2014}
\abx@aux@segm{0}{0}{Chiva2014}
\abx@aux@cite{Choi:2017jan}
\abx@aux@segm{0}{0}{Choi:2017jan}
\abx@aux@cite{Cox:2014fi}
\abx@aux@segm{0}{0}{Cox:2014fi}
\abx@aux@cite{Meierhofer2016}
\abx@aux@segm{0}{0}{Meierhofer2016}
\abx@aux@cite{Picotti09}
\abx@aux@segm{0}{0}{Picotti09}
\abx@aux@cite{Surinova:2015jn}
\abx@aux@segm{0}{0}{Surinova:2015jn}
\@writefile{lot}{\defcounter {refsection}{0}\relax }\@writefile{lot}{\contentsline {table}{\numberline {S1}{\ignorespaces  \relax }}{6}{}\protected@file@percent }
\newlabel{tab:dataDescriptionSpikein}{{S1}{6}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {section}{\numberline {4}Experimental datasets in this manuscript}{6}{}\protected@file@percent }
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{\numberline {4.1}Experiments with known ground truth}{6}{}\protected@file@percent }
\newlabel{sec:sim}{{4.1}{6}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.1.1}Computer simulation}{6}{}\protected@file@percent }
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.1.2}Dataset 1 : Computer simulation 1 - Label-free}{6}{}\protected@file@percent }
\newlabel{dataset1}{{4.1.2}{6}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.1.3}Dataset 2 : Computer simulation 2 - Label-free missing values and low replicates}{7}{}\protected@file@percent }
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S3}{\ignorespaces FDR of Simulation 1.\relax }}{9}{}\protected@file@percent }
\newlabel{fig:sim1_fpr}{{S3}{9}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S4}{\ignorespaces Recall and Accuracy results of Simulation 1.\relax }}{10}{}\protected@file@percent }
\newlabel{fig:sim1_recall}{{S4}{10}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S5}{\ignorespaces \relax }}{11}{}\protected@file@percent }
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S6}{\ignorespaces Recall results of Simulation 2. The advantage of using the proposed approach is apparent when looking at simulation 2, which includes limited observations and the presence of missing values. In the case of recall the proposed method performs stronger than Limma and t-test in nearly every model. Even at lower replicates the proposed method still outperformed Limma. Again the lowest performing method was $t$-test.\relax }}{11}{}\protected@file@percent }
\newlabel{fig:sim2_recall}{{S6}{11}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S7}{\ignorespaces Fold change distribution comparison between Simulations 1 and 2.\relax }}{12}{}\protected@file@percent }
\newlabel{fig:fc_boxplot}{{S7}{12}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.1.4}Dataset 3 : SpikeIn benchmark - Ubiquitination - Label-free}{13}{}\protected@file@percent }
\newlabel{sec:benchmark}{{4.1.4}{13}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S8}{\ignorespaces An overview of the spike-in benchmark experimental design. The corresponding levels of spike-in peptide, human lysate, and background lysate for each mixture are shown. The spike-in peptide levels are adjusted for the human lysate levels. For example, the true spike-in abundance of mixture 1 is entirely accounted for by human lysate, whereas mix 2 has double the amount human lysate compared to spike-in abundance. When comparing mix 1 vs mix 2 we would expect to see a log fold change of -1. In this way we know the expected log fold change between mixture comparisons. \relax }}{13}{}\protected@file@percent }
\newlabel{fig:spikein_overview}{{S8}{13}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S9}{\ignorespaces The modeling results of the proposed method both before and after adjustment. The spike-in peptides are colored red and the background peptides are colored grey. All grey peptides are expected to be insignificant. Using the proposed method to model the benchmark experiment, the spike-in peptides (colored red) do not follow the expected log fold change before adjustment. After adjusting for changes in overall protein abundance the spike-in peptides are more in line with expectation. Additionally the background grey colored peptides show many false positives before adjustment. After adjustment these false positives were decreased considerably. \relax }}{14}{}\protected@file@percent }
\newlabel{fig:spike_volcano_msstats}{{S9}{14}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S10}{\ignorespaces When modeling the experiment with the Limma method, the spike-in peptides again follow the expected log fold change better after adjusting for changes in protein level. However, while the fold change is much more accurate, the majority of spike-in peptides do not have a significant adjusted pvalue. In this case, the known differential peptides are missed by the model. In terms of false positives, the results are very similar to the proposed method, with many false positives before adjustment and much fewer after. \relax }}{15}{}\protected@file@percent }
\newlabel{fig:spike_volcano_limma}{{S10}{15}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S11}{\ignorespaces Using the two sample $t$-test, none of the comparisons either before or after adjustment show any significant peptides. With that being said, the fold change of the spike-in peptides is much closer to expectation after adjusting for global protein abundance. \relax }}{16}{}\protected@file@percent }
\newlabel{fig:spike_volcano_ttest}{{S11}{16}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S12}{\ignorespaces Comparing the summary statistics between methods it is clear that the proposed method performs the strongest. In terms of accuracy and specificity the three methods are close, with Limma and $t$-test showing slightly higher values. Accuracy and specificity are dominated by the large number of true negatives (background peptides) compared to the true positives (spike-in peptides). In terms of recall, the proposed approach far out performed the other two methods, showing that it correctly labeled the most spike-in peptides. \relax }}{17}{}\protected@file@percent }
\newlabel{fig:spike_stat}{{S12}{17}}
\abx@aux@cite{LUCHETTI2021}
\abx@aux@segm{0}{0}{LUCHETTI2021}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsection}{\numberline {4.2}Biological investigations}{18}{}\protected@file@percent }
\newlabel{sec:bio_investigations}{{4.2}{18}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.2.1}Dataset 4 : Human - Ubiquitination - 1mix-TMT}{18}{}\protected@file@percent }
\newlabel{sec:ipah}{{4.2.1}{18}}
\@writefile{lot}{\defcounter {refsection}{0}\relax }\@writefile{lot}{\contentsline {table}{\numberline {S2}{\ignorespaces The experimental design of Dataset 4\relax }}{18}{}\protected@file@percent }
\newlabel{table:ipah_design}{{S2}{18}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S13}{\ignorespaces Summary plots for modification of protein GSDMD at site K62.\relax }}{19}{}\protected@file@percent }
\newlabel{fig:ipah_figures}{{S13}{19}}
\abx@aux@cite{Maculins}
\abx@aux@segm{0}{0}{Maculins}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.2.2}Dataset 5 : Mouse - Phosphorylation - 2mix-TMT time series}{20}{}\protected@file@percent }
\newlabel{sec:shigella}{{4.2.2}{20}}
\@writefile{lot}{\defcounter {refsection}{0}\relax }\@writefile{lot}{\contentsline {table}{\numberline {S3}{\ignorespaces The experimental design of Dataset 5\relax }}{20}{}\protected@file@percent }
\newlabel{table:shigella_design}{{S3}{20}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S14}{\ignorespaces Summary plots for modification of protein TTP at site S178.\relax }}{21}{}\protected@file@percent }
\newlabel{fig:No_Diff_Shigella_PTM}{{S14}{21}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S15}{\ignorespaces Summary plots for modification of protein KI67 at site T215.\relax }}{22}{}\protected@file@percent }
\newlabel{fig:Diff_Shigella_PTM}{{S15}{22}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {subsubsection}{\numberline {4.2.3}Dataset 6 : Human - Ubiquitination - Label-free no global profiling run}{23}{}\protected@file@percent }
\newlabel{sec:usp30}{{4.2.3}{23}}
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S16}{\ignorespaces Comparing the global profiling of protein $P52209$ with the modification of the protein at site $K059$. The modification appears generally unchanged between all conditions, whereas the global profiling run shows the CCCP and Combo conditions have a higher relative abundance compared to the Control and USP30\_OE. This indicates that the modification actually had an effect when comparing CCCP and Combo to Control and USP30\_OE. However it is not entirely clear as one unmodified peptide feature appears to be changed, while the other does not. This uncertainty is another result of not running a separate global profiling run. With a global profiling run, many unmodified features are generally quantified, removing the uncertainty that comes with low feature counts.\relax }}{23}{}\protected@file@percent }
\newlabel{fig:USP30_profile_plot}{{S16}{23}}
\@writefile{toc}{\defcounter {refsection}{0}\relax }\@writefile{toc}{\contentsline {section}{\numberline {5}Sample size calculation and power analysis}{24}{}\protected@file@percent }
\@writefile{lof}{\defcounter {refsection}{0}\relax }\@writefile{lof}{\contentsline {figure}{\numberline {S17}{\ignorespaces Power analysis of experiments with differing variances.\relax }}{25}{}\protected@file@percent }
\newlabel{fig:power_sd_combo}{{S17}{25}}
\abx@aux@read@bbl@mdfivesum{22DC12AB1C92156D292F1494EF933E49}
\abx@aux@refcontextdefaultsdone
\abx@aux@defaultrefcontext{0}{Ritchie_15a}{none/global//global/global}
\abx@aux@defaultrefcontext{0}{LUCHETTI2021}{none/global//global/global}
\abx@aux@defaultrefcontext{0}{Maculins}{none/global//global/global}
\gdef \@abspage@last{26}
